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Background: PCI in the presence of angiographically visible thrombus is associated with worse clinical outcomes. Whether recent advances in 
devices and adjunctive pharmacotherapy have made any significant impact on clinical outcomes is unknown. Moreover, concerns have been raised 
about the safety of DES in thrombotic lesions. Hence,the aim of our study was to evaluate the temporal trends in outcomes following percutaneous 
coronary intervention (PCI) in lesions with angiographically visible thrombus and to assess the impact of drug eluting stents (DES) on long-term 
outcomes.
Methods: We conducted a retrospective analysis of 6227 consecutive patients who had angiographically visible thrombus. Patients were grouped 
into 3 eras depending on the dominant interventional strategy of that time: early stent era (1990-1996), bare metal stent era (1997-2003), and 
DES era (2003-2006).
Results Procedural success rates, though much improved, have remained unchanged in the last 2 cohorts (43%, 85%, 86%, p<0.001). Major 
adverse cardiovascular events decreased modestly (7.8%, 5.7%, 6.1%, p=0.021), but in-hospital mortality has remained unchanged over time (4.7%, 
3.5%, 4.3%, p=0.40). During long-term follow-up, mortality and the combined endpoint of death or myocardial infarction (MI) were similar in the 3 
cohorts, but the combined endpoint of death, MI or TLR (p<0.001) was lower in the 2 most recent eras.
Conclusions: There has been a marked improvement in procedural success and a modest decrease in MACE rates. However, in-hospital 
mortality has not decreased. Importantly, the introduction of DES has not been associated with a greater risk of death or MI among patients with 
angiographically visible thrombus.
